Publications by authors named "Lorraine Teng"

Vitamin C is a potent antioxidant in vitro and has been reported to act as a vasodilator, possibly by increasing nitric oxide bioavailability. This study examined the antioxidant and vascular effects of a single large oral dose of vitamin C in 26 healthy human volunteers. Haemodynamic and oxidative DNA and lipid damage markers were measured for 8 h following an oral dose of 2 g vitamin C or placebo.

View Article and Find Full Text PDF

Background: Ruboxistaurin, a specific inhibitor of the beta(1) and beta(2) isoforms of protein kinase C, is currently in clinical development for the treatment of several diabetic microvascular complications. The major metabolite, N-desmethyl ruboxistaurin (metabolite 338522), is equipotent in its inhibitory activity. The elimination of ruboxistaurin and its metabolites is primarily through bile and the faecal route, with urinary excretion constituting only a minor route.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Lorraine Teng"

  • Lorraine Teng's research primarily focuses on the effects of various compounds, such as vitamin C and ruboxistaurin, on health outcomes, particularly in relation to oxidative stress and chronic conditions.
  • One study demonstrated that acute oral ingestion of a large dose of vitamin C did not significantly impact oxidative stress, arterial stiffness, or blood pressure in healthy individuals, suggesting limited benefits in those parameters.
  • Another study assessed the pharmacokinetics of ruboxistaurin in patients with chronic renal failure, providing insights into how this medication's elimination varies in populations with kidney dysfunction, which is relevant for treating diabetic complications.